Agency Forms Undergoing Paperwork Reduction Act Review, 61218-61219 [2016-21273]
Download as PDF
<![CDATA[
61218
Federal Register / Vol. 81, No. 172 / Tuesday, September 6, 2016 / Notices
departments nationwide do not
participate. The FBI’s National Incident
Based Reporting System (NIBRS)
provides slightly more information than
SHRs, but it covers less of the country
than SHRs. NIBRS also only provides
data regarding homicides. Also, the
Bureau of Justice Statistics Reports do
not use data that is less than two years
old.
CDC requests OMB approval in order
to revise its state-based surveillance
system for violent deaths that will
provide more detailed and timely
information. The surveillance system
captures case record information held
by medical examiners/coroners, vital
statistics (i.e., death certificates), and
law enforcement. Data is collected by
each state in the system and entered
into a web system administered by CDC.
Information is collected from these
records about the characteristics of the
victims and suspects, the circumstances
The president has submitted plans to
fund the expansion of the state-based
surveillance system to collect
information in all 50 U.S. states, the
District of Columbia, and U.S.
territories. This revision will allow 10
new state health departments, and 7
territorial governments to be added to
the currently funded 39 state health
departments (Maine and Vermont are
funded as one entity), the health
department of the District of Columbia,
and 1 territorial government, resulting
in a total of 59 states and territories to
be included in the state-based
surveillance system. Violent deaths
include all homicides, suicides, legal
interventions, deaths from
undetermined causes, and unintentional
firearm deaths. The average state will
experience approximately 1,000 such
deaths each year.
There are no costs to respondents
other than their time.
of the deaths, and the weapons
involved. States use standardized data
elements and software designed by CDC.
Ultimately, this information will guide
states in designing, targeting, and
evaluating programs that reduce
multiple forms of violence. Neither
victim’s families nor suspects are
contacted to collect this information; it
all comes from existing records and is
collected by state health department
staff or their subcontractors. The
number of hours per death required for
the public agencies working with
NVDRS states to retrieve and then refile
their records is estimated to be 0.5 hours
per death. Moving forward, we will no
longer include state abstractors’ time
spent abstracting data in our estimates
of public burden for NVDRS because
state abstractors are funded by CDC to
do this work. This significantly reduces
the estimated public burden associated
with NVDRS.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Public Agencies ................................
NVDRS Web System .......................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–21296 Filed 9–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–16XD]
mstockstill on DSK3G9T082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
VerDate Sep<11>2014
17:04 Sep 02, 2016
Jkt 238001
59
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1,000
Total burden
hours
(in hours)
30/60
29,500
comments should be received within 30
days of this notice.
Proposed Project
Practice Patterns Related to Opioid
Use during Pregnancy and Lactation—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Over the past decade, the prevalence
of maternal opioid use during
pregnancy has steadily increased. The
use of opioids or other psychoactive
substances, either by illicit abuse or by
nonmedical abuse of prescription
opioids, increases the risks for health
and social problems for both mother and
infant. For example, maternal substance
abuse during pregnancy increases the
risk of preterm birth, low birth weight,
perinatal death, and neonatal abstinence
syndrome (NAS). For many women, and
some at-risk women in particular,
prenatal visits may be the only time
they routinely see a physician. Because
obstetrician-gynecologists (OB/GYNs)
are the principal health care providers
for women, OB/GYNs are well situated
to screen for substance use and to treat
or encourage cessation of substance use
during pregnancy. Thus, it is important
E:\FR\FM\06SEN1.SGM
06SEN1
61219
Federal Register / Vol. 81, No. 172 / Tuesday, September 6, 2016 / Notices
to understand current provider
knowledge, attitudes, and practices
regarding maternal opioid use.
CDC, in collaboration with the
American College of Obstetricians and
Gynecologists (ACOG), plans to conduct
a survey to address this gap in
knowledge. Survey respondents will be
ACOG Fellows and Junior Fellows who
have a current medical license and are
in medical practice focused on women’s
health. ACOG is separated into 11
districts, one of which represents OB/
GYN members who are in the U.S.
military. The remaining 10 ACOG
districts correspond to geographic
regions that encompass the entire
United States and Canada. Survey
invitations will be sent to a quasirandom sample of ACOG members in
each district.
CDC and ACOG estimate that 1,500
individuals will be contacted in order to
obtain a study target of 600 respondents.
The initial invitation will be distributed
by email with instructions on
completing a web-based version of the
questionnaire. Three to four months
after the initial invitation, a paper
version of the questionnaire will be
distributed to individuals who have not
completed the online version. The
estimated number of respondents for the
full web-based or paper questionnaire is
420 and the estimated burden per
response is 15 minutes. Approximately
6 weeks after the second recruitment
attempt, ACOG will distribute a short
version of the questionnaire to any nonresponders. The estimated number of
responses for the short version of the
questionnaire is 180 and the estimated
burden per response is 5 minutes. An
overall 40% response rate is expected.
The survey will collect information
about provider attitudes and beliefs
regarding maternal opioid use, their
screening and referral practices for
pregnant or postpartum patients,
barriers to screening and treating
pregnant and postpartum patients for
opioid use, and resources that are
needed to improve treatment and
referral. No information will be
collected about individual patients.
Survey administration and data
management will be conducted by
ACOG, and participation is voluntary.
De-identified response data will be
shared with CDC for analysis. Findings
will be used to create recommendations
for educational programs and patient
care. The total estimated annualized
burden hours are 120. There are no costs
to participants other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
OB/GYNs caring for pregnant
women.
Practice Patterns related to Opioid Use during Pregnancy
and Lactation—Full survey.
Practice Patterns related to Opioid Use during Pregnancy
and Lactation—Short introduction and survey.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–21273 Filed 9–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Ethnic Community Self-Help
Program Data Indicators.
OMB No.: 0970–NEW.
Description: The ACF Office of
Refugee Resettlement proposes to
Number of
responses per
respondent
Average
burden per
response
(in hours)
420
1
15/60
180
1
5/60
collect information from Ethnic
Community-Based Organizations
(ECBOs) awarded federal funds under
HHS–2016–ACF–ORR–1129. The
information, collected through a
questionnaire, is expected to provide
information on Program objectives semiannually in order for program staff to
gauge the Program’s progress for
reporting and evaluation purposes.
Respondents: ECBOs awarded under
HHS–2016–ACF–ORR–1129.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ECSH Data Indicators .....................................................................................
mstockstill on DSK3G9T082PROD with NOTICES
Instrument
10
2
1
20
Estimated Total Annual Burden
Hours: 20.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW., Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
VerDate Sep<11>2014
17:04 Sep 02, 2016
Jkt 238001
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV. Attn:
E:\FR\FM\06SEN1.SGM
06SEN1
]]>Agencies
[Federal Register Volume 81, Number 172 (Tuesday, September 6, 2016)]
[Notices]
[Pages 61218-61219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-16XD]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Practice Patterns Related to Opioid Use during Pregnancy and
Lactation--New--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Over the past decade, the prevalence of maternal opioid use during
pregnancy has steadily increased. The use of opioids or other
psychoactive substances, either by illicit abuse or by nonmedical abuse
of prescription opioids, increases the risks for health and social
problems for both mother and infant. For example, maternal substance
abuse during pregnancy increases the risk of preterm birth, low birth
weight, perinatal death, and neonatal abstinence syndrome (NAS). For
many women, and some at-risk women in particular, prenatal visits may
be the only time they routinely see a physician. Because obstetrician-
gynecologists (OB/GYNs) are the principal health care providers for
women, OB/GYNs are well situated to screen for substance use and to
treat or encourage cessation of substance use during pregnancy. Thus,
it is important
[[Page 61219]]
to understand current provider knowledge, attitudes, and practices
regarding maternal opioid use.
CDC, in collaboration with the American College of Obstetricians
and Gynecologists (ACOG), plans to conduct a survey to address this gap
in knowledge. Survey respondents will be ACOG Fellows and Junior
Fellows who have a current medical license and are in medical practice
focused on women's health. ACOG is separated into 11 districts, one of
which represents OB/GYN members who are in the U.S. military. The
remaining 10 ACOG districts correspond to geographic regions that
encompass the entire United States and Canada. Survey invitations will
be sent to a quasi-random sample of ACOG members in each district.
CDC and ACOG estimate that 1,500 individuals will be contacted in
order to obtain a study target of 600 respondents. The initial
invitation will be distributed by email with instructions on completing
a web-based version of the questionnaire. Three to four months after
the initial invitation, a paper version of the questionnaire will be
distributed to individuals who have not completed the online version.
The estimated number of respondents for the full web-based or paper
questionnaire is 420 and the estimated burden per response is 15
minutes. Approximately 6 weeks after the second recruitment attempt,
ACOG will distribute a short version of the questionnaire to any non-
responders. The estimated number of responses for the short version of
the questionnaire is 180 and the estimated burden per response is 5
minutes. An overall 40% response rate is expected.
The survey will collect information about provider attitudes and
beliefs regarding maternal opioid use, their screening and referral
practices for pregnant or postpartum patients, barriers to screening
and treating pregnant and postpartum patients for opioid use, and
resources that are needed to improve treatment and referral. No
information will be collected about individual patients. Survey
administration and data management will be conducted by ACOG, and
participation is voluntary. De-identified response data will be shared
with CDC for analysis. Findings will be used to create recommendations
for educational programs and patient care. The total estimated
annualized burden hours are 120. There are no costs to participants
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
OB/GYNs caring for pregnant women.. Practice Patterns related 420 1 15/60
to Opioid Use during
Pregnancy and Lactation--
Full survey.
Practice Patterns related 180 1 5/60
to Opioid Use during
Pregnancy and Lactation--
Short introduction and
survey.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-21273 Filed 9-2-16; 8:45 am]
BILLING CODE 4163-18-P
